Results 1 to 10 of about 710,167 (255)
Searching for potential acetylcholinesterase inhibitors: a combined approach of multi-step similarity search, machine learning and molecular dynamics simulations [PDF]
Targeting acetylcholinesterase is one of the most important strategies for developing therapeutics against Alzheimer’s disease. In this work, we have employed a new approach that combines machine learning models, a multi-step similarity search of the ...
Quynh Mai Thai +4 more
doaj +3 more sources
New series of indole derivatives analogous to donepezil, a well known anti-Alzheimer and acetylcholinesterase inhibitor drug, was synthesized. A full chemical characterization of the new compounds is provided.
Lamia W Mohamed, Mona M Kamel
exaly +3 more sources
Design of novel pyrazole and benzofuran-based derivatives as potent acetylcholinesterase inhibitors for Alzheimer’s disease management [PDF]
IntroductionBeing a complex neurodegenerative disease with many clinical features, Alzheimer’s disease calls for multiple-targeted drugs to treat several aspects of its progression in the human body.
Mohamed El Fadili +6 more
doaj +2 more sources
Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer’s Disease: A Narrative Review [PDF]
While acetylcholinesterase inhibitors are used to treat a wide range of patients with Alzheimer’s disease, acetylcholinesterase inhibitor use has also been associated with a variety of cardiovascular complications, including bradycardia and syncope ...
Sara Young, Enoch Chung, Michael A. Chen
doaj +1 more source
Overactive bladder prevalence increases in older adults often complicating the management of other comorbidities. The theoretical antagonism between the parasympathetic-blocking anticholinergic agent and the parasympathetic stimulatory agents ...
Jonathan H. Watanabe, Tu Hoang
doaj +1 more source
Structure-based virtual screening protocol to identify potent acetylcholinesterase inhibitors was retrospectively validated. The protocol could be employed to examine the potential of designed compounds as novel acetylcholinesterase inhibitors.
Vivitri Dewi Prasasty +1 more
doaj +1 more source
Alzheimer’s disease (AD), a neurodegenerative brain disorder that affects millions of people worldwide, is characterized by memory loss and cognitive decline.
Stergiani-Chrysovalanti Peitzika +1 more
doaj +1 more source
In search of novel and more potent p-aminobenzoic acid derivatives previously evaluated as effective acetylcholinesterase inhibitors for the control of Alzheimer’s disease (AD), an integrated computational approach of three-dimensional quantitative ...
Khalil El Khatabi +6 more
doaj +3 more sources
Acetylcholinesterase inhibitors reduce neuroinflammation and -degeneration in the cortex and hippocampus of a surgery stress rat model. [PDF]
Exogenous stress like tissue damage and pathogen invasion during surgical trauma could lead to a peripheral inflammatory response and induce neuroinflammation, which can result in postoperative cognitive dysfunction (POCD).
Alexander Kalb +7 more
doaj +1 more source
A quinoxaline scaffold exhibits various bioactivities in pharmacotherapeutic interests. In this research, twelve quinoxaline derivatives were synthesized and evaluated as new acetylcholinesterase inhibitors.
Paptawan Suwanhom +5 more
doaj +1 more source

